Nexalin Technology Inc (NASDAQ: NXL) is 7.61% higher on its value in year-to-date trading and has touched a low of $0.25 and a high of $4.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NXL stock was last observed hovering at around $3.19 in the last trading session, with the day’s loss setting it -0.22%.
Currently trading at $2.97, the stock is -7.88% and -14.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.39 million and changing -6.90% at the moment leaves the stock 67.08% off its SMA200. NXL registered 722.03% gain for a year compared to 6-month gain of 104.83%. The firm has a 50-day simple moving average (SMA 50) of $3.4517 and a 200-day simple moving average (SMA200) of $1.765135.
The stock witnessed a -31.88% loss in the last 1 month and extending the period to 3 months gives it a 336.76%, and is 7.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.20% over the week and 11.67% over the month.
Nexalin Technology Inc (NXL) has around 6 employees, a market worth around $39.51M and $0.16M in sales. Profit margin for the company is -3427.10%. Distance from 52-week low is 1074.84% and -33.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-112.04%).
13.0 institutions hold shares in Nexalin Technology Inc (NXL), with institutional investors hold 3.14% of the company’s shares. The shares outstanding are 12.86M, and float is at 10.36M with Short Float at 4.74%. Institutions hold 2.41% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 59805.0 shares valued at $0.1 million. The investor’s holdings represent 0.8042 of the NXL Shares outstanding. As of 2024-06-30, the second largest holder is CVI HOLDINGS, LLC with 55462.0 shares valued at $93731.0 to account for 0.7458 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 44062.0 shares representing 0.5925 and valued at over $74464.0, while ATRIA WEALTH SOLUTIONS, INC. holds 0.5165 of the shares totaling 38413.0 with a market value of $64918.0.
Nexalin Technology Inc (NXL) Insider Activity
The most recent transaction is an insider purchase by Owens David, the company’s Chief Medical Officer. SEC filings show that Owens David bought 500 shares of the company’s common stock on Oct 28 ’24 at a price of $2.19 per share for a total of $1095.0. Following the purchase, the insider now owns 0.15 million shares.
Nexalin Technology Inc disclosed in a document filed with the SEC on Aug 13 ’24 that Owens David (Chief Medical Officer) bought a total of 1,000 shares of the company’s common stock. The trade occurred on Aug 13 ’24 and was made at $0.95 per share for $950.0. Following the transaction, the insider now directly holds 0.15 million shares of the NXL stock.
Still, SEC filings show that on Jun 28 ’24, Owens David (Chief Medical Officer) acquired 1,000 shares at an average price of $1.75 for $1750.0. The insider now directly holds 146,793 shares of Nexalin Technology Inc (NXL).
